UK
UK
Oct-23
Oct-23
Oct-23
Sep-23
Aug-23
Aug-23
Jul-23
Jul-23
Jul-23
Jun-23
| Date | Title | Categories | |
|---|---|---|---|
| Oct-23 | Impact of ACEIs and ARBs-related adverse drug reaction on patients’ clinical outcomes: a cohort study in UK primary care | Read more | |
| Oct-23 | SGLT2 inhibitors associated with decreased risk of nephrolithiasis compared to GLP-1 receptor agonists: An active comparator, new user cohort study | Read more | |
| Oct-23 | Incidence of Cardiovascular Disease and Venous Thromboembolism in Patients With Atopic Dermatitis | Read more | |
| Oct-23 | Mental Health Conditions and COVID-19 vaccine outcomes: a scoping review | Read more | |
| Sep-23 | Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database | Read more | |
| Aug-23 | Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial emulation framework | Read more | |
| Aug-23 | Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes | Read more | |
| Aug-23 | Incretins and cardiovascular disease: to the heart of type 2 diabetes? | Read more | |
| Jul-23 | Risk of incident sleep disorders in patients with prurigo nodulRisk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network | Read more | |
| Jul-23 | Malignancy risk in patients with atopic dermatitis: a population-based cohort study | Read more | |
| Jul-23 | Attention-deficit hyperactivity disorder diagnoses and prescriptions in UK primary care, 2000–2018: population-based cohort study | Read more | |
| Jun-23 | The risk of all-cause mortality associated with anxiety: a retrospective cohort study using ‘The Health Improvement Network’ database | Read more |
